What GRI Bio Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hertz Walter Marc | Chief Executive Officer | Apr 21 | Grant / award · A | +385,510 | — | — | 385,510 |
| Chaturvedi Vipin | Chief Scientific Officer | Apr 21 | Grant / award · A | +172,189 | — | — | 172,189 |
| Agro Albert | Chief Medical Officer | Apr 21 | Grant / award · A | +172,189 | — | — | 172,189 |
| Thorell Marella | Director | Dec 13 | Other Transaction · J | −28,517 | — | — | 9,506 |
| Thorell Marella | Director | Jul 01 | Grant / award · A | +38,023 | — | — | 38,023 |
| Kelly Leanne M. | Chief Financial Officer | Jun 04 | Open-market buy · P | +1,508 | $4.08 | +$6.15K | 6,250 |
| Kelly Leanne M. | Chief Financial Officer | Jun 03 | Open-market buy · P | +1,085 | $4.05 | +$4.39K | 4,742 |
| Kelly Leanne M. | Chief Financial Officer | Jun 02 | Open-market buy · P | +3,657 | $4.00 | +$14.6K | 3,657 |
| Payne Joseph E | Director | May 26 | Open-market buy · P | +6,800 | $4.50 | +$30.6K | 17,500 |
| Payne Joseph E | Director | May 25 | Open-market buy · P | +10,700 | $3.85 | +$41.2K | 10,700 |
| Baker David Charles | Chief Executive Officer | Feb 12 | Open-market buy · P | +1,000 | $8.00 | +$8K | 8,843 |
| Baker David Charles | Chief Executive Officer | Feb 12 | Other Transaction · J | +7,843 | $6.40 | +$50.2K | 7,843 |
| Salmon Pharma GmbH | 10% owner | Feb 12 | Other Transaction · J | +47,063 | $6.40 | +$301K | 47,063 |
| Ammer Richard | Director | Feb 12 | Other Transaction · J | +47,063 | $6.40 | +$301K | 47,063 |
Loading...